Article Details

Roche CEO O'Day: Our investment in Flatiron will accelerate their mission

Retrieved on: 2018-03-02 04:59:59

Tags for this article:

Click the tags to see associated articles and topics

Roche CEO O'Day: Our investment in Flatiron will accelerate their mission. View article details on hiswai:

Excerpt

<div>Roche's purchase of <b>Flatiron Health</b> will accelerate the development of real-world data suitable for supporting regulatory decisions, said Daniel O'Day, CEO of Roche Pharmaceuticals. “They have very good coverage of cancer lives in the United States, but it's roughly 30 percent, so they have the scale ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up